Related Experiment Video
Updated: Feb 1, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
Polymorphisms in XPC gene and risk for prostate cancer
Rahma Said1,2, Karim Bougatef3, Nouha Setti Boubaker1
1Laboratory of Protein Engineering and Bio-active Molecules, National Institute of Applied Science and Technology - University of Carthage, Tunis, Tunisia.
Certain DNA repair gene variations, like XPC PAT I/I, increase prostate cancer risk. Other XPC gene variants may offer protection, highlighting complex genetic links to prostate cancer susceptibility.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- Single nucleotide polymorphisms (SNPs) in DNA repair genes, such as the XPC gene, can impair DNA repair capacity (DRC).
- Reduced DRC is linked to genetic instability and potentially increased susceptibility to prostate cancer (PC).
Purpose of the Study:
- To investigate the association between XPC Lys939Gln and XPC-PAT polymorphisms and prostate cancer risk in the Tunisian population.
- To correlate these genetic findings with clinical parameters and lifestyle factors in prostate cancer patients.
Main Methods:
- A case-control study design was employed.
- Genotyping for XPC Lys939Gln and XPC-PAT polymorphisms was performed.
- Statistical analyses, including linkage disequilibrium testing and odds ratio calculations, were conducted.
Main Results:
- The XPC Lys939Gln polymorphism showed no association with prostate cancer risk.
- The XPC PAT I/I genotype was significantly associated with a 3.83-fold increased risk of prostate cancer (p = 0.00006).
- Combined analysis revealed that individuals with (Lys/Gln + PAT D/D) genotypes were protected against prostate cancer. No significant associations were found between XPC polymorphisms and clinical or lifestyle factors.
Conclusions:
- The XPC PAT I/I genotype is a risk factor for prostate cancer in Tunisia.
- Specific combined genotypes of XPC Lys939Gln and XPC-PAT may confer protection against prostate cancer.
- XPC gene polymorphisms are not significantly associated with clinical parameters or lifestyle factors in prostate cancer patients.
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Relative Risk
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Single Nucleotide Polymorphisms-SNPs
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...

